These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 31107572)

  • 21. Prospective, randomized, multinational study of prostatic urethral lift versus transurethral resection of the prostate: 12-month results from the BPH6 study.
    Sønksen J; Barber NJ; Speakman MJ; Berges R; Wetterauer U; Greene D; Sievert KD; Chapple CR; Montorsi F; Patterson JM; Fahrenkrug L; Schoenthaler M; Gratzke C
    Eur Urol; 2015 Oct; 68(4):643-52. PubMed ID: 25937539
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contemporary monopolar and bipolar transurethral resection of the prostate: prospective assessment of complications using the Clavien system.
    De Nunzio C; Lombardo R; Autorino R; Cicione A; Cindolo L; Damiano R; De Sio M; Falsaperla M; Franco G; Gacci M; Leonardo C; Presicce F; Tubaro A
    Int Urol Nephrol; 2013 Aug; 45(4):951-9. PubMed ID: 23722819
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Photovaporization of the prostate with GreenLight™ laser 180 W XPS versus transurethral resection of the prostate with monopolar energy for the treatment of benign prostatic enlargement: a cost-utility analysis from a healthcare perspective.
    Caicedo JI; Taborda A; Robledo D; Bravo-Balado A; Domínguez C; Trujillo CG; Cataño JG; Campos Hernández J; Londoño Trujillo D; Plata M
    World J Urol; 2019 May; 37(5):861-866. PubMed ID: 30116964
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Moderate-to-high cardiovascular risk is associated with increased lower urinary tract storage symptoms in patients with benign prostatic enlargement.
    De Nunzio C; Truscelli G; Presicce F; Bellangino M; Gacci M; Gaudio C; Tubaro A
    Minerva Urol Nefrol; 2018 Jun; 70(3):340-346. PubMed ID: 29478309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction.
    Oelke M; Bachmann A; Descazeaud A; Emberton M; Gravas S; Michel MC; N'dow J; Nordling J; de la Rosette JJ;
    Eur Urol; 2013 Jul; 64(1):118-40. PubMed ID: 23541338
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Connections between lower urinary tract symptoms related to benign prostatic enlargement and metabolic syndrome with its components: a systematic review and meta-analysis.
    Russo GI; Castelli T; Urzì D; Privitera S; Fragalà E; La Vignera S; Condorelli RA; Calogero AE; Favilla V; Cimino S; Morgia G
    Aging Male; 2015; 18(4):207-16. PubMed ID: 26171768
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation and management of post-transurethral resection of the prostate lower urinary tract symptoms.
    Chughtai B; Simma-Chiang V; Kaplan SA
    Curr Urol Rep; 2014 Sep; 15(9):434. PubMed ID: 25037906
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reply: To PMID 26194291.
    De Nunzio C; Presicce F; Tubaro A
    Urology; 2015 Aug; 86(2):366-7. PubMed ID: 26194299
    [No Abstract]   [Full Text] [Related]  

  • 29. Editorial Comment.
    Scarpa RM; Usai P; Cracco CM
    Urology; 2015 Aug; 86(2):365-6. PubMed ID: 26194291
    [No Abstract]   [Full Text] [Related]  

  • 30. Usage of GreenLight HPS 180-W laser vaporisation for treatment of benign prostatic hyperplasia.
    Jovanović M; Džamić Z; Aćimović M; Kajmaković B; Pejčić T
    Acta Chir Iugosl; 2014; 61(1):57-61. PubMed ID: 25782227
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Systematic Review and Meta-analysis of Functional Outcomes and Complications Following Transurethral Procedures for Lower Urinary Tract Symptoms Resulting from Benign Prostatic Obstruction: An Update.
    Cornu JN; Ahyai S; Bachmann A; de la Rosette J; Gilling P; Gratzke C; McVary K; Novara G; Woo H; Madersbacher S
    Eur Urol; 2015 Jun; 67(6):1066-1096. PubMed ID: 24972732
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bipolar transurethral vaporization: a superior procedure in benign prostatic hyperplasia: a prospective randomized comparison with bipolar TURP.
    Falahatkar S; Mokhtari G; Moghaddam KG; Asadollahzade A; Farzan A; Shahab E; Ghasemi A; Allahkhah A; Esmaeili S
    Int Braz J Urol; 2014; 40(3):346-55. PubMed ID: 25010300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Quality of life in patients with lower urinary tract symptoms after TURP for benign prostatic hyperplasia].
    Pushkar DY; Bernikov AN; Khodyreva LA; Dudareva AA; Al'-Shukri SK; Amdii RE; Aboyan IA; Shiranov KA; Medvedev VL; Efremov ME
    Urologiia; 2018 Mar; (1):53-61. PubMed ID: 29634135
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transurethral resection of prostate with plasmakinetic energy: 100 months results of a prospective randomized trial.
    Muslumanoglu AY; Yuruk E; Binbay M; Akman T
    BJU Int; 2012 Aug; 110(4):546-9. PubMed ID: 22115409
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Impact of medical and surgical treatments of LUTS on nocturia].
    Robert G; De La Taille A; Descazeaud A
    Prog Urol; 2018 Nov; 28(15):848-855. PubMed ID: 30268350
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors of sexual dysfunction after transurethral resection of the prostate (TURP): a 12 months follow-up.
    Favilla V; Cimino S; Salamone C; Fragalà E; Madonia M; Condorelli R; La Vignera S; Mongioì L; Pirozzi Farina F; Russo GI; Morgia G
    J Endocrinol Invest; 2013 Dec; 36(11):1094-8. PubMed ID: 24445123
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomized Controlled Trial of Aquablation versus Transurethral Resection of the Prostate in Benign Prostatic Hyperplasia: One-year Outcomes.
    Gilling PJ; Barber N; Bidair M; Anderson P; Sutton M; Aho T; Kramolowsky E; Thomas A; Cowan B; Roehrborn C
    Urology; 2019 Mar; 125():169-173. PubMed ID: 30552937
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Editorial comment to Tamsulosin versus transurethral resection of the prostate: effect on nocturia due to benign prostatic hyperplasia.
    Milićević S
    Int J Urol; 2011 Mar; 18(3):248-9. PubMed ID: 21332818
    [No Abstract]   [Full Text] [Related]  

  • 39. Analysis of risk factors leading to postoperative urethral stricture and bladder neck contracture following transurethral resection of prostate.
    Tao H; Jiang YY; Jun Q; Ding X; Jian DL; Jie D; Ping ZY
    Int Braz J Urol; 2016; 42(2):302-11. PubMed ID: 27256185
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between metabolic syndrome and intravesical prostatic protrusion in patients with benign prostatic enlargement and lower urinary tract symptoms (MIPS Study).
    Russo GI; Regis F; Spatafora P; Frizzi J; Urzì D; Cimino S; Serni S; Carini M; Gacci M; Morgia G
    BJU Int; 2018 May; 121(5):799-804. PubMed ID: 28872764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.